Mauna Kea Technologies SA
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions… Read more
Market Cap & Net Worth: Mauna Kea Technologies SA (MKEAF)
Mauna Kea Technologies SA (PINK:MKEAF) has a market capitalization of $25.87 Million ($25.87 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #26069 globally and #8852 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mauna Kea Technologies SA's stock price $0.37 by its total outstanding shares 69932096 (69.93 Million).
Mauna Kea Technologies SA Market Cap History: 2015 to 2025
Mauna Kea Technologies SA's market capitalization history from 2015 to 2025. Data shows change from $279.73 Million to $25.87 Million (-22.29% CAGR).
Mauna Kea Technologies SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mauna Kea Technologies SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.38x
Mauna Kea Technologies SA's market cap is 3.38 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $279.73 Million | $9.98 Million | -$12.64 Million | 28.03x | N/A |
| 2016 | $202.80 Million | $8.79 Million | -$9.74 Million | 23.08x | N/A |
| 2017 | $373.44 Million | $6.69 Million | -$10.24 Million | 55.85x | N/A |
| 2018 | $237.77 Million | $6.76 Million | -$12.79 Million | 35.17x | N/A |
| 2019 | $67.13 Million | $8.51 Million | -$15.27 Million | 7.89x | N/A |
| 2020 | $109.09 Million | $6.53 Million | -$12.79 Million | 16.72x | N/A |
| 2021 | $97.90 Million | $7.70 Million | -$13.45 Million | 12.71x | N/A |
| 2022 | $29.37 Million | $7.48 Million | -$11.18 Million | 3.93x | N/A |
| 2023 | $29.37 Million | $11.03 Million | -$3.73 Million | 2.66x | N/A |
| 2024 | $25.87 Million | $7.66 Million | -$10.40 Million | 3.38x | N/A |
Competitor Companies of MKEAF by Market Capitalization
Companies near Mauna Kea Technologies SA in the global market cap rankings as of March 19, 2026.
Key companies related to Mauna Kea Technologies SA by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Mauna Kea Technologies SA Historical Marketcap From 2015 to 2025
Between 2015 and today, Mauna Kea Technologies SA's market cap moved from $279.73 Million to $ 25.87 Million, with a yearly change of -22.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $25.87 Million | 0.00% |
| 2024 | $25.87 Million | -11.90% |
| 2023 | $29.37 Million | 0.00% |
| 2022 | $29.37 Million | -70.00% |
| 2021 | $97.90 Million | -10.26% |
| 2020 | $109.09 Million | +62.50% |
| 2019 | $67.13 Million | -71.76% |
| 2018 | $237.77 Million | -36.33% |
| 2017 | $373.44 Million | +84.14% |
| 2016 | $202.80 Million | -27.50% |
| 2015 | $279.73 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Mauna Kea Technologies SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $25.87 Million USD |
| MoneyControl | $25.87 Million USD |
| MarketWatch | $25.87 Million USD |
| marketcap.company | $25.87 Million USD |
| Reuters | $25.87 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.